Charles River Poster Presentations
Neuroscience 2017 is a forum for Charles River scientists to showcase key findings from independent research and collaborative efforts with top scientists from across the globe. During this year’s meeting, Charles River scientists from multiple sites and scientific disciplines presented scientific posters either independently or collaboratively with our clients. Click on the title to view an electronic file of the poster.
Technologies
-
Pharmacological MRI – In Vivo Imaging Platform for Pre-clinical CNS Drug Discovery (245.23/OO20)
Artem Shatillo, Tuukka Miettinen, Janika Keinänen, Antti Nurmi
Charles River, Kuopio, Finland -
Autoradiography Methodologies in CNS Research (716.12/VV31)
Jussi Rytkönen, Teija Parkkari, Outi Kontkanen, Antti Nurmi, Tuulia Huhtala
Charles River, Kuopio, Finland -
Imaging of Dopamine Transporter in Rodents Using PET and SPECT (756.09/M5)
Tuulia Huhtala1, Jussi Rytkönen1, Pekka Poutiainen2, 3, Raimo Pussinen1, Teija Parkkari1, Antti Nurmi1
1Charles River, Kuopio, Finland, 2A.I. Virtanen Institute for Molecular Medicine, University of Eastern Finland, Kuopio, Finland, 3Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital, Finland -
Jussi Rytkönen1, Pekka Poutiainen2, 3, Teija Parkkari1, Antti Nurmi1, Tuulia Huhtala1
1Charles River, Kuopio, Finland, 2A.I. Virtanen Institute for Molecular Medicine, University of Eastern Finland, Kuopio, Finland, 3Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital, Finland -
Preclinical PET Imaging of CNS Diseases in Rodent Models (756.10/M6)
Jussi Rytkönen1, Pekka Poutiainen2, 3, Artem Shatillo1, Kimmo Lehtimäki1, Karoliina Soininen1, Tuulia Huhtala1
1Charles River, Kuopio, Finland, 2A.I. Virtanen Institute for Molecular Medicine, University of Eastern Finland, Kuopio, Finland, 3Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital, Finland -
Nicholas Moore1, Carlos A. Cordeiro1, 2, T. Koster1, L. Kuhl1, Joost HA Folgering1, Thomas IF Cremers1,2
1Brains On-Line, a Charles River company, Groningen, the Netherlands, 2University of Groningen, Dept. of Pharmaceutical Analysis, Groningen, the Netherlands
Parkinson's Disease
-
Administration of AAV Alpha-synuclein to C57BL6/J and G2019s Mice (048.18/V4)
Robert Hodgson1, Jere Kurkipuro1, Teija Parkkari1, Terina Martinez2, Matthew Fell3, Taneli Heikkinen1, Lynn Hyde3, Antti Nurmi1, Thomas Lanz4, Antonia Stepan4, Marco Baptista2
1Charles River, Kuopio, Finland; 2Michael J Fox Foundation, New York, NY; 3Merck & Co. Inc., Boston, MA; 4Pfizer Inc, Cambridge, MA -
Administration of AAV Alpha-synuclein in SD and G2019S-LRRK2 Rats (048.19/V5)
Robert Hodgson1, Teija Parkkari1, Terina Martinez2, Matthew Fell3, Laura Koistinen1, Tuulia Huhtala1, Jussi Rytkönen1, Pekka Poutiainen5,6, Jere Kurkipuro1, Lynn Hyde3, Antti Nurmi1, Thomas Lanz4, Antonia Stepan4, Marco Baptista2
1Charles River, Kuopio, Finland; 2Michael J Fox Foundation, New York, NY; 3Merck & Co. Inc., Boston, MA; 4Pfizer Inc, Cambridge, MA; 5A.I. Virtanen Institute for Molecular Medicine, University of Eastern Finland, Kuopio, Finland; 6Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital, Finland -
Behavioral Consequences of Administration of AAV Alpha-synuclein to Rat (048.20/V6)
Robert Hodgson1, Teija Parkkari1, Terina Martinez2, Matthew Fell3, Laura Koistinen1, Timo Bragge1, Lynn Hyde3, Antti Nurmi1, Thomas Lanz4, Antonia Stepan4, Marco Baptista2
1Charles River, Kuopio, Finland; 2Michael J Fox Foundation, New York, NY; 3Merck & Co. Inc., Boston, MA; 4Pfizer Inc, Cambridge, MA -
L. Yu, A. Rassoulpour, H. Janssens, M. van der Hart, T. Cremers
Brains On-Line, a Charles River Company, South San Francisco, CA -
Kimmo Lehtimäki, Jere Kurkipuro, Jukka Puoliväli, Tuulia Huhtala, Antti Nurmi
Charles River, Kuopio, Finland -
Robert Hodgson, Antti Nurmi, Laura Koistinen
Charles River, Kuopio, Finland -
Folkert Verkaar1, Terina Martinez2, Astrid Jensen1, Toni Wolinsky1, David F. Fischer1, Jeroen DeGroot1 and Blandine Mille-Baker1
1Charles River Laboratories, Darwinweg 24, 2333 CR, Leiden, The Netherlands, 2The Michael J. Fox Foundation for Parkinson’s Research, 498 Seventh Avenue, NY 10018, New York, USA -
Evaluation of Constipation Endpoints in MPTP-treated Mice (133.25/W19)
Ramio Pussinen, Antti Nurmi, Robert Hodgson
Charles River, Kuopio, Finland -
AC Morse1, R Hodgson2, RO Pussinen2, J Korkalainen2, M Suhonen2, AJ Nurmi2, JA VIivian3
1Neuropharm., Dart NeuroScience, San Diego, CA; 2Charles River Discovery, Kuopio, Finland; 3Dart Neurosci., San Diego, CA
Alzheimer's Disease
-
Jukka Puoliväli, Kimmo Lehtimäki, Tuulia Huhtala, Jussi Rytkönen, Antti Nurmi
Charles River, Kuopio, Finland
Huntington's Disease
-
Maksym V. Kopanitsa, Tuukka Piiponniemi, Teija Parkkari, Antti Nurmi
Charles River, Kuopio, Finland
Multiple Sclerosis
-
Antti Nurmi1, Maksym V. Kopanitsa1, Kimmo Lehtimäki1, Markku E. Forsman1, Ari Suhonen1, Juho Koponen1, Avia Merenlender-Wagner2, Joel Kaye2, Aric Orbach2
1Charles River, Kuopio, Finland; 2Teva Pharmaceutical Industries Ltd., Netanya, Israel -
Tuulia Huhtala, Jere Kurkipuro, Laura Koistinen, Maria Vihma, Anniina Oksman, Leena Tähtivaara, Antti Nurmi
Charles River, Kuopio, Finland
Pain
-
Analgesics Assessment in Rat MIA Model Using the Bioseb Automated Dynamic Weight Bearing System
Harun Rashid, Julie Douville and Rana Samadfam
Charles River, Montreal
Learn How We Can Support You Through The Entire Neuroscience Research Process